CD8A and breast carcinoma: Suitable animal models are required to precisely determine prognostic roles of CD4+ and CD8+ T cells with different distribution origins in breast cancer, which should not only provide new prognostic information but also be a key for the development and clinical application of novel immunotherapeutic strategies in human breast cancer.